Private Advisory Group’s AbbVie ABBV Stock Holding History

Private Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$798K	Buy	3,169 +810	+34%	+$174K	0.04%	187
2026 Q1	$513K	Buy	2,359 +411	+21%	+$91.2K	0.03%	198
2025 Q4	$445K	Sell	1,948 -109	-5%	-$24.8K	0.03%	165
2025 Q3	$476K	Buy	2,057 +494	+32%	+$101K	0.04%	156
2025 Q2	$290K	Sell	1,563 -315	-17%	-$58.5K	0.03%	180
2025 Q1	$393K	Sell	1,878 -70	-4%	-$13.6K	0.04%	151
2024 Q4	$346K	Buy	1,948 +610	+46%	+$112K	0.04%	163
2024 Q3	$264K	Sell	1,338 -54	-4%	-$10.1K	0.03%	175
2024 Q2	$239K	Sell	1,392 -312	-18%	-$51.7K	0.03%	161
2024 Q1	$310K	Buy	+1,704	New	+$294K	0.04%	156
2023 Q1	–	Sell	-1,260	Closed	-$204K	–	198
2022 Q4	$204K	Buy	+1,260	New	+$193K	0.04%	185
2022 Q3	–	Sell	-1,721	Closed	-$264K	–	179
2022 Q2	$264K	Buy	+1,721	New	+$263K	0.06%	138
2018 Q1	–	Sell	-3,825	Closed	-$370K	–	101
2017 Q4	$370K	Buy	+3,825	New	+$360K	0.2%	98

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Private Advisory Group's ABBV Position: Q2 2026 in Review

Private Advisory Group increased its AbbVie (ABBV) stake by 34% in Q2 2026, buying an estimated $174K and bringing the position to 3,169 shares worth $798K. The position accounts for 0.04% of the portfolio, ranked #187.

Private Advisory Group first reported a position in ABBV in Q4 2017 and has held it in 13 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Private Advisory Group held 3,169 shares of AbbVie worth $798K as of Q2 2026.
Private Advisory Group bought 810 AbbVie shares in Q2 2026, an estimated $174K.
AbbVie made up 0.04% of Private Advisory Group's portfolio in Q2 2026, its #187 holding.
Private Advisory Group first reported a position in AbbVie in Q4 2017 and has held it in 13 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.